ISEC Healthcare Ltd. (SGX:40T)
Singapore · Delayed Price · Currency is SGD 0.3100
+0.0200 (6.90%)
At close: Oct 20, 2026
ISEC Healthcare Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 83.67 | 79.21 | 74.2 | 69.99 | 62.95 | 40.47 | |
Revenue Growth | 6.84% | 6.76% | 6.00% | 11.18% | 55.56% | 11.40% |
Cost of Revenue | 50.21 | 45.85 | 41.53 | 38.96 | 34.19 | 22.59 |
Gross Profit | 33.47 | 33.36 | 32.67 | 31.04 | 28.77 | 17.88 |
Selling, General & Admin | 17.07 | 15.74 | 14.12 | 12.26 | 10.43 | 8.62 |
Other Operating Expenses | 0.13 | 0.1 | 0.44 | 0.55 | 1.45 | 0.57 |
Operating Expenses | 17.2 | 15.84 | 14.56 | 12.81 | 11.88 | 9.18 |
Operating Income | 16.26 | 17.52 | 18.11 | 18.23 | 16.88 | 8.69 |
Interest Expense | -0.62 | -0.64 | -0.6 | -0.65 | -0.56 | -0.4 |
Interest & Investment Income | 0.36 | 0.36 | 0.33 | 0.3 | - | 0.22 |
Earnings From Equity Investments | - | - | - | - | -0 | -0.01 |
Currency Exchange Gain (Loss) | -0.24 | 0.02 | 0.69 | -0.72 | - | -0.13 |
Other Non Operating Income (Expenses) | 0.6 | 0.29 | 0.07 | 0.05 | 0.44 | 0.33 |
EBT Excluding Unusual Items | 16.36 | 17.55 | 18.6 | 17.19 | 16.77 | 8.7 |
Merger & Restructuring Charges | - | - | - | - | - | -0.05 |
Impairment of Goodwill | - | - | -1.52 | - | - | - |
Asset Writedown | - | - | -0.01 | -0.01 | - | -0 |
Other Unusual Items | 0.16 | 0.16 | 0.12 | 0.13 | 0.01 | 0.44 |
Pretax Income | 16.52 | 17.71 | 17.19 | 17.31 | 16.78 | 9.09 |
Income Tax Expense | 4.5 | 4.29 | 4.29 | 4.16 | 4.05 | 2.21 |
Earnings From Continuing Operations | 12.02 | 13.42 | 12.89 | 13.15 | 12.73 | 6.88 |
Minority Interest in Earnings | 0.04 | -0.05 | -0.07 | -0.19 | -0.21 | 0.03 |
Net Income | 12.05 | 13.37 | 12.82 | 12.96 | 12.52 | 6.91 |
Net Income to Common | 12.05 | 13.37 | 12.82 | 12.96 | 12.52 | 6.91 |
Net Income Growth | -5.10% | 4.23% | -1.07% | 3.54% | 81.32% | 47.23% |
Shares Outstanding (Basic) | 576 | 576 | 575 | 573 | 564 | 550 |
Shares Outstanding (Diluted) | 576 | 576 | 576 | 573 | 564 | 550 |
Shares Change | - | 0.02% | 0.38% | 1.73% | 2.42% | 0.52% |
EPS (Basic) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
EPS (Diluted) | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
EPS Growth | -5.19% | 4.04% | -1.33% | 1.80% | 77.60% | 45.93% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.59 | -0.57 | 5.86 | 13.75 | 12.14 | 11.57 |
Free Cash Flow Per Share | 0.00 | -0.00 | 0.01 | 0.02 | 0.02 | 0.02 |
Dividend Per Share | - | 0.006 | 0.010 | 0.016 | 0.016 | 0.011 |
Dividend Growth | - | -42.00% | -37.89% | 3.21% | 48.57% | 31.25% |
Gross Margin | 40.00% | 42.12% | 44.03% | 44.34% | 45.70% | 44.18% |
Operating Margin | 19.44% | 22.12% | 24.40% | 26.04% | 26.82% | 21.48% |
Profit Margin | 14.40% | 16.88% | 17.28% | 18.52% | 19.89% | 17.06% |
Free Cash Flow Margin | 0.71% | -0.73% | 7.90% | 19.65% | 19.28% | 28.58% |
EBITDA | 18.81 | 19.93 | 20.28 | 20.22 | 18.58 | 10.31 |
EBITDA Margin | 22.48% | 25.16% | 27.33% | 28.89% | 29.52% | 25.48% |
D&A For EBITDA | 2.54 | 2.41 | 2.17 | 2 | 1.7 | 1.62 |
EBIT | 16.26 | 17.52 | 18.11 | 18.23 | 16.88 | 8.69 |
EBIT Margin | 19.44% | 22.12% | 24.40% | 26.04% | 26.82% | 21.48% |
Effective Tax Rate | 27.26% | 24.23% | 24.98% | 24.05% | 24.14% | 24.29% |